Featured Research

from universities, journals, and other organizations

Researchers identify two HIV-1 envelope immunogens capable of eliciting antibodies associated with vaccine protection

Date:
January 24, 2014
Source:
Seattle Biomedical Research Institute (Seattle BioMed)
Summary:
Researchers identified two HIV-1 Envelope immunogens that elicit broadly neutralizing antibodies when introduced as a vaccine.

Seattle BioMed researchers identified two HIV-1 Envelope immunogens that elicit broadly neutralizing antibodies when introduced as a vaccine. The study was published online in PLOS One.

The HIV-1 Envelope protein immunogens were derived from an elite neutralizer, an individual with an unusually potent antibody response effective against the majority of HIV subtypes. Seattle BioMed researchers identified two Envelope immunogens that elicited cross-reactive binding antibodies to the variable regions 1 and 2 (V1V2) region of the envelope protein and induced antibodies capable of neutralizing an array of HIV from different subtypes.

"Previous studies have shown that anti-HIV-1 neutralizing antibodies can effectively block infection with HIV-1 if present prior to infection with the virus," said Noah Sather, Ph.D. principal scientist at Seattle BioMed and corresponding author of the study. "In addition, antibodies that target a specific part of the Envelope protein, the V1V2 region, have been shown in clinical trials to be associated with a reduced risk of infection. Thus, the ideal vaccine would introduce immunogens that elicit antibodies both targeted to the V1V2 region of the Envelope protein and capable of providing protection from a wide variety of HIV-1 subtypes."

Follow on studies will focus on further modifying the Envelope immunogens to increase the potency and effectiveness of the vaccine.

The HIV-1 epidemic remains a significant threat to global health, with 2.3 million new HIV-1 infections and 1.6 million AIDS-related deaths each year. While access to anti-retroviral therapies has increased, the best route of defeating the epidemic is still a universally effective HIV-1 vaccine.


Story Source:

The above story is based on materials provided by Seattle Biomedical Research Institute (Seattle BioMed). Note: Materials may be edited for content and length.


Journal Reference:

  1. Sara Carbonetti, Brian G. Oliver, Jolene Glenn, Leonidas Stamatatos, D. Noah Sather. Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies. PLoS ONE, 2014; 9 (1): e86905 DOI: 10.1371/journal.pone.0086905

Cite This Page:

Seattle Biomedical Research Institute (Seattle BioMed). "Researchers identify two HIV-1 envelope immunogens capable of eliciting antibodies associated with vaccine protection." ScienceDaily. ScienceDaily, 24 January 2014. <www.sciencedaily.com/releases/2014/01/140124101737.htm>.
Seattle Biomedical Research Institute (Seattle BioMed). (2014, January 24). Researchers identify two HIV-1 envelope immunogens capable of eliciting antibodies associated with vaccine protection. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/01/140124101737.htm
Seattle Biomedical Research Institute (Seattle BioMed). "Researchers identify two HIV-1 envelope immunogens capable of eliciting antibodies associated with vaccine protection." ScienceDaily. www.sciencedaily.com/releases/2014/01/140124101737.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins